Literature DB >> 24105791

Proteomic profiling identified multiple short-lived members of the central proteome as the direct targets of the addicted oncogenes in cancer cells.

Tonggang Qi1, Wei Zhang, Yun Luan, Feng Kong, Dawei Xu, Guanghui Cheng, Yunshan Wang.   

Abstract

"Oncogene addiction" is an unexplained phenomenon in the area of cancer targeted therapy. In this study, we have tested a hypothesis that rapid apoptotic response of cancer cells following acute inhibition of the addicted oncogenes is because of loss of multiple short-lived proteins whose activity normally maintain cell survival by blocking caspase activation directly or indirectly. It was shown that rapid apoptotic response or acute apoptosis could be induced in both A431 and MiaPaCa-2 cells, and quick down-regulation of 17 proteins, which were all members of the central proteome of human cells, was found to be associated with the onset of acute apoptosis. Knockdown of PSMD11 could partially promote the occurrence of acute apoptosis in both MiaPaCa-2 and PANC-1 pancreatic cancer cells. These findings indicate that maintaining the stability of central proteome may be a primary mechanism for addicted oncogenes to maintain the survival of cancer cells through various signaling pathways, and quick loss of some of the short-lived members of the central proteome may be the direct reason for the rapid apoptotic response or acute apoptosis following acute inhibition of the addicted oncogenes in cancer cells. These findings we have presented can help us better understand the phenomenon of oncogene-addiction and may have important implications for the targeted therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105791      PMCID: PMC3879629          DOI: 10.1074/mcp.M113.027813

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  48 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes.

Authors:  Sreenath V Sharma; Patrycja Gajowniczek; Inna P Way; Diana Y Lee; Jane Jiang; Yuki Yuza; Marie Classon; Daniel A Haber; Jeffrey Settleman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Structural roles for human translation factor eIF3 in initiation of protein synthesis.

Authors:  Bunpote Siridechadilok; Christopher S Fraser; Richard J Hall; Jennifer A Doudna; Eva Nogales
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

4.  Rapid turnover of mcl-1 couples translation to cell survival and apoptosis.

Authors:  Kenneth W Adams; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

Review 5.  Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy.

Authors:  I Bernard Weinstein; Andrew K Joe
Journal:  Nat Clin Pract Oncol       Date:  2006-08

6.  Vinblastine induces acute, cell cycle phase-independent apoptosis in some leukemias and lymphomas and can induce acute apoptosis in others when Mcl-1 is suppressed.

Authors:  Bethany L Salerni; Darcy J Bates; Tina C Albershardt; Christopher H Lowrey; Alan Eastman
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

7.  Phosphorylation of eEF1A1 at Ser300 by TβR-I results in inhibition of mRNA translation.

Authors:  Kah Wai Lin; Ihor Yakymovych; Min Jia; Mariya Yakymovych; Serhiy Souchelnytskyi
Journal:  Curr Biol       Date:  2010-09-09       Impact factor: 10.834

8.  Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation.

Authors:  Johannes A Mayr; Franz A Zimmermann; Christine Fauth; Christa Bergheim; David Meierhofer; Doris Radmayr; Johannes Zschocke; Johannes Koch; Wolfgang Sperl
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

9.  Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism.

Authors:  D Tang; J M Lahti; J Grenet; V J Kidd
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

10.  Initial characterization of the human central proteome.

Authors:  Thomas R Burkard; Melanie Planyavsky; Ines Kaupe; Florian P Breitwieser; Tilmann Bürckstümmer; Keiryn L Bennett; Giulio Superti-Furga; Jacques Colinge
Journal:  BMC Syst Biol       Date:  2011-01-26
View more
  6 in total

Review 1.  The role of TXNL1 in disease: treatment strategies for cancer and diseases with oxidative stress.

Authors:  Jin-Ming Zhao; Tong-Gang Qi
Journal:  Mol Biol Rep       Date:  2021-03-03       Impact factor: 2.316

2.  Identification of key candidate genes involved in melanoma metastasis.

Authors:  Jia Chen; Fei Wu; Yu Shi; Degang Yang; Mingyuan Xu; Yongxian Lai; Yeqiang Liu
Journal:  Mol Med Rep       Date:  2019-05-30       Impact factor: 2.952

3.  DNLC: differential network local consistency analysis.

Authors:  Jianwei Lu; Yao Lu; Yusheng Ding; Qingyang Xiao; Linqing Liu; Qingpo Cai; Yunchuan Kong; Yun Bai; Tianwei Yu
Journal:  BMC Bioinformatics       Date:  2019-12-24       Impact factor: 3.169

4.  Generation and identification of a conditional knockout allele for the PSMD11 gene in mice.

Authors:  Linlin Zhao; Jinming Zhao; Yingying Zhang; Lele Wang; Longyan Zuo; Airu Niu; Wei Zhang; Xia Xue; Suhong Zhao; Chao Sun; Kailin Li; Jue Wang; Zhimin Bian; Xiaogang Zhao; Dieter Saur; Barbara Seidler; Chuanxin Wang; Tonggang Qi
Journal:  BMC Dev Biol       Date:  2021-02-01       Impact factor: 1.978

5.  RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma.

Authors:  Wangyang Zheng; Yuling Zheng; Xue Bai; Yongxu Zhou; Liang Yu; Daolin Ji; Kaiming Leng; Nanfeng Meng; Hang Wang; ZiYue Huang; Yi Xu; Yunfu Cui
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

6.  Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.

Authors:  Ye Zhang; Yin-Long Yang; Fang-Lin Zhang; Xiao-Hong Liao; Zhi-Min Shao; Da-Qiang Li
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.